SLC5A2 and hydrops fetalis: The current “four-pillar therapy” for HF includes ACE inhibitors (ACEi) or angiotensin receptor-neprilysin inhibitors (ARNI), beta-blockers, mineralocorticoid receptor antagonists (MRAs), and sodium-glucose cotransporter-2 inhibitors (SGLT2i).